Emerson Electric Co.
NYSE:EMRIndustrial - Machinery
+$2.10 today
- Market cap
- $88.87B
- Beta
- 1.25
- P/E (TTM)
- 34.7
- EPS (TTM)
- $4.36
- Dividend yield
- 1.45%
Volume 2.90M
Average 2.88M
EMR EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Emerson Electric Co.NYSE: EMR
EBITDA · Q3 FY2026 · quarter ended Jun 2026
EBITDA growth accelerates
Q3 FY2026 EBITDA of $1.38B rose 14.7% year over year, ahead of the +11.2% change in trailing-twelve-month EBITDA. Sequentially, it rose 8.3% from the prior quarter. Over 3 fiscal years it compounded at +11.4% a year.
Context
- EBITDA amounted to 26.9% of revenue in FY2025, up 3.8 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 20 analysts of $5.88B (+21.6%) for the fiscal year ending Sep 2026, a step up from the +20.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.38B+8.3% QoQ
- Last fiscal yearSep 2025
- $4.84B+20.0% YoY
- LTMJun 2026
- $5.32B+11.2% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +14.7% | +12.5% | -2.3 pp |
| 1 year | +20.0% | +21.6% | +1.6 pp |
| 3-year CAGR | +11.4% | +9.3% | -2.0 pp |
| 5-year CAGR | +7.9% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
USD · from the income statement
- Latest · FY2025
- 4.84B USD
- Year-over-year change
- +20.0%
- 4-year CAGR
- +15.8%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-09-30 | 4.84B | +20.0% |
| FY2024 | 2024-09-30 | 4.03B | -4.3% |
| FY2023 | 2023-09-30 | 4.22B | +20.4% |
| FY2022 | 2022-09-30 | 3.5B | +30.2% |
| FY2021 | 2021-09-30 | 2.69B | — |
EBITDA vs competitors
How EMR compares with its peers on the latest reported figures
- EMR's LTM Jun 2026 EBITDA of $5.32B is the 3rd highest of the 8 companies compared; the peer median is $1.93B.
- Its year-over-year change of +11.2% is the 4th highest of 8, against a peer median of +10.3%.
- EBITDA amounts to 28.5% of revenue for EMR, versus a peer median of 22.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $6.46B | +9.4% | +16.2% | 21.5% | |
| LTM Jun 2026 | $5.9B | +8.8% | +13.2% | 27.4% | |
| LTM Jun 2026 | $5.32B | +11.2% | +11.4% | 28.5% | |
| LTM Jun 2026 | $3.76B | +13.0% | +15.4% | 15.1% | |
| LTM Sep 2026 | $1.93B | +6.4% | +4.9% | 22.5% | |
| LTM Jun 2026 | $1.77B | +10.3% | -0.9% | 19.7% | |
| LTM Jun 2026 | $1.07B | +48.4% | +22.4% | 22.1% | |
| LTM Jun 2026 | $957.8M | +12.1% | -0.2% | 26.7% | |
| Peer median (excluding EMR) | $1.93B | +10.3% | +13.2% | 22.1% | |
Competitors are the stored peer set for EMR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Sep 2021 | FY2022 Sep 2022 | FY2023 Sep 2023 | FY2024 Sep 2024 | FY2025 Sep 2025 |
|---|---|---|---|---|---|
| Revenue | 12.93B | 13.8B | 15.17B | 17.49B | 18.02B |
| Cost of Revenue | 7.2B | 7.5B | 7.74B | 8.61B | 8.5B |
| Gross Profit | 5.73B | 6.31B | 7.43B | 8.89B | 9.52B |
| Gross Margin | 44.3% | 45.7% | 49.0% | 50.8% | 52.8% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 3.49B | 3.61B | 4.19B | 5.14B | 5.1B |
| Operating Expenses | 3.77B | 3.95B | 4.67B | 6.22B | 5.99B |
| Depreciation & Amortization | 762M | 842M | 1.05B | 1.69B | 1.52B |
| EBITDA | 2.69B | 3.5B | 4.22B | 4.03B | 4.84B |
| EBITDA Margin | 20.8% | 25.4% | 27.8% | 23.1% | 26.9% |
| Operating Income | 1.96B | 2.36B | 2.76B | 2.67B | 3.53B |
| Operating Margin | 15.1% | 17.1% | 18.2% | 15.2% | 19.6% |
| Interest Income | 12M | 34M | 268M | 234M | 150M |
| Interest Expense | 166M | 228M | 261M | 323M | 387M |
| Other Income / Expenses | (197M) | 76M | 144M | (646M) | (598M) |
| Income Before Tax | 1.76B | 2.43B | 2.9B | 2.02B | 2.93B |
| Pre-Tax Margin | 13.6% | 17.6% | 19.1% | 11.5% | 16.3% |
| Income Tax Expense | 346M | 549M | 642M | 415M | 696M |
| Net Income | 2.3B | 3.23B | 13.22B | 1.97B | 2.29B |
| Net Margin | 17.8% | 23.4% | 87.2% | 11.3% | 12.7% |
| EPS (Basic) | 3.85 | 4.63 | 3.75 | 3.44 | 4.07 |
| EPS (Diluted) | 3.83 | 4.60 | 3.73 | 3.43 | 4.04 |
| Weighted Avg Shares | 598.1M | 592.9M | 574.2M | 571.3M | 562.8M |
| Weighted Avg Shares (Diluted) | 601.8M | 592.9M | 577.3M | 574M | 566.7M |
Emerson Electric Co.
NYSE:EMR
Intrinsic Alpha fair value
Locked
Current Price
$162.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.